MR1 presents vitamin B6-related compounds for recognition by MR1-reactive T cells.

Autor: McInerney MP; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Awad W; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Souter MNT; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3052, Australia., Kang Y; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3052, Australia., Wang CJH; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Chan Yew Poa K; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Abdelaal MR; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Le NH; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Shepherd CM; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., McNeice C; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Meehan LJ; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3052, Australia., Nelson AG; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3052, Australia., Raynes JM; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Mak JYW; Centre for Chemistry and Drug Discovery and Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD 4072, Australia., McCluskey J; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3052, Australia., Chen Z; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3052, Australia., Ang CS; Mass Spectrometry and Proteomics Facility, Bio21 Institute, The University of Melbourne, Parkville, VIC 3052, Australia., Fairlie DP; Centre for Chemistry and Drug Discovery and Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD 4072, Australia., Le Nours J; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Illing PT; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia., Rossjohn J; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.; Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF10 3AT, United Kingdom., Purcell AW; Department of Biochemistry and Molecular Biology and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Dec 03; Vol. 121 (49), pp. e2414792121. Date of Electronic Publication: 2024 Nov 26.

Increasing Medicaid's Stagnant Asset Test For People Eligible For Medicare And Medicaid Will Help Vulnerable Seniors.

Autor: Cornelio N; Noelle Cornelio (noc17@pitt.edu) is a doctoral student in the Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, in Pittsburgh, Pennsylvania., McInerney MP; Melissa Powell McInerney is a professor in the Department of Economics, Tufts University, in Medford, Massachusetts., Mellor JM; Jennifer M. Mellor is the Paul R. Verkuil Professor of Economics and Public Policy in the Department of Economics and directs the Schroeder Center for Health Policy at William & Mary, in Williamsburg, Virginia., Roberts ET; Eric T. Roberts is an assistant professor in the Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health., Sabik LM; Lindsay M. Sabik is an associate professor in the Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health.

Publikováno v: Health affairs (Project Hope) [Health Aff (Millwood)] 2021 Dec; Vol. 40 (12), pp. 1943-1952.

Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide.

Autor: Li P; Oral Drug Delivery Innovation, Lonza Global R&D, Melbourne, Australia., Ford L; Oral Drug Delivery Innovation, Lonza Global R&D, Melbourne, Australia., Haque S; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia., McInerney MP; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia., Williams HD; Oral Drug Delivery Innovation, Lonza Global R&D, Melbourne, Australia., Scammells PJ; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia., Thompson PE; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia., Jannin V; Oral Drug Delivery Innovation, Lonza Global R&D, Strasbourg, France., Porter CJH; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia. chris.porter@monash.edu.; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia. chris.porter@monash.edu., Benameur H; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia. hassan.benameur@monash.edu.; Oral Drug Delivery Innovation, Lonza Global R&D, Strasbourg, France. hassan.benameur@monash.edu., Pouton CW; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia. colin.pouton@monash.edu.

Publikováno v: Pharmaceutical research [Pharm Res] 2021 Jun; Vol. 38 (6), pp. 1125-1137. Date of Electronic Publication: 2021 Jun 07.

Ionophore and Biometal Modulation of P-glycoprotein Expression and Function in Human Brain Microvascular Endothelial Cells.

Autor: McInerney MP; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences,, Monash University,, 381 Royal Parade, Parkville, VIC,, 3052, Australia., Volitakis I; The Florey Institute of Neuroscience and Mental Health,, Parkville, VIC, Australia., Bush AI; The Florey Institute of Neuroscience and Mental Health,, Parkville, VIC, Australia., Banks WA; Division of Gerontology and Geriatric Medicine, Department of Medicine,, University of Washington School of Medicine, Seattle, Washington,, USA.; Geriatrics Research Education and Clinical Center,, Veterans Affairs Puget Sound Health Care System,, Seattle, Washington,, USA., Short JL; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University,, Parkville, VIC,, Australia., Nicolazzo JA; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences,, Monash University,, 381 Royal Parade, Parkville, VIC,, 3052, Australia. joseph.nicolazzo@monash.edu.

Publikováno v: Pharmaceutical research [Pharm Res] 2018 Mar 05; Vol. 35 (4), pp. 83. Date of Electronic Publication: 2018 Mar 05.

Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.

Autor: McInerney MP; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia., Short JL; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia., Nicolazzo JA; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia. joseph.nicolazzo@monash.edu.

Publikováno v: The AAPS journal [AAPS J] 2017 Jul; Vol. 19 (4), pp. 940-956. Date of Electronic Publication: 2017 May 01.